These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 13423624)

  • 1. [Kala azar and cutaneous leishmaniasis in Yugoslavia].
    TODOROVIC K
    Zentralbl Bakteriol Orig; 1957 Jan; 167(5):390-5. PubMed ID: 13423624
    [No Abstract]   [Full Text] [Related]  

  • 2. [Phlebotome fauna in Yugoslavia and their role in the epidemiology of pappataci fever, kala-azar and cutaneous leishmaniasis].
    SIMITCH T; ZIVKOVITCH V
    Arch Inst Pasteur Alger; 1956; 34(3):380-7. PubMed ID: 13395612
    [No Abstract]   [Full Text] [Related]  

  • 3. Short communication: post-kala-azar dermal leishmaniasis--an appraisal.
    Ramesh V; Singh R; Salotra P
    Trop Med Int Health; 2007 Jul; 12(7):848-51. PubMed ID: 17596251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-kala-azar dermal leishmaniasis and visceral leishmaniasis in a child--or is it para-kala-azar dermal leishmaniasis?
    Mendiratta V; Chander R
    Int J Dermatol; 2009 Sep; 48(9):1027-8. PubMed ID: 19703001
    [No Abstract]   [Full Text] [Related]  

  • 5. On the differences between post-kala-azar dermal leishmaniasis and leprosy.
    Ramesh V
    Trop Doct; 1994 Jul; 24(3):120-1. PubMed ID: 8091519
    [No Abstract]   [Full Text] [Related]  

  • 6. Orally effective drugs for kala-azar (visceral leishmaniasis): focus on miltefosine and sitamaquine.
    Sangraula H; Sharma KK; Rijal S; Dwivedi S; Koirala S
    J Assoc Physicians India; 2003 Jul; 51():686-90. PubMed ID: 14621038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneity of cutaneous leishmaniasis with emphasis on the Old World.
    Peters W
    Schweiz Med Wochenschr; 1993 Jun; 123(24):1237-49. PubMed ID: 8327872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-kala-azar dermal leishmaniasis with visceral leishmaniasis, or a rare presentation of visceral leishmaniasis with extensive skin manifestations.
    Ramesh V
    Int J Dermatol; 2007 Dec; 46(12):1326. PubMed ID: 18173544
    [No Abstract]   [Full Text] [Related]  

  • 9. Post kala azar dermal leishmaniasis in Sudan.
    Kordofani YM; Nour YT; El-Hassan AM; Shalayel MH
    East Mediterr Health J; 2001 Nov; 7(6):1061-4. PubMed ID: 15332749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post kala-azar dermal leishmaniasis (PKDL): a first case report from Nepal.
    Karki P; Koirala S; Parija SC; Sethi M; Das ML
    Indian J Pathol Microbiol; 2003 Apr; 46(2):214-5. PubMed ID: 15022913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Current point of leishmaniasis epidemiology in Algeria].
    Harrat Z; Hamrioui B; Belkaid M; Tabet-Derraz O
    Bull Soc Pathol Exot; 1995 Mar; 88(4):180-4. PubMed ID: 8640081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-kala-azar dermal leishmaniasis with visceral leishmaniasis: a rare presentation.
    Rijal A; Agrawal S; Agarwalla A; Agrawal A; Rijal S
    Int J Dermatol; 2005 Jun; 44(6):494-6. PubMed ID: 15941439
    [No Abstract]   [Full Text] [Related]  

  • 13. Post-kala-azar dermal leishmaniasis.
    VARMA SR
    J Indian Med Assoc; 1957 May; 28(10):436-7. PubMed ID: 13439194
    [No Abstract]   [Full Text] [Related]  

  • 14. Cutaneous leishmaniasis: report of rare cases in Nepal.
    Neupane S; Sharma P; Kumar A; Paudel U; Pokhrel DB
    Nepal Med Coll J; 2008 Mar; 10(1):64-7. PubMed ID: 18700634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Landscape-epidemiological zoning of Turkmenistan by leishmaniasis].
    Ponirovskiĭ EN; Darchenkova NN
    Med Parazitol (Mosk); 2008; (1):27-30. PubMed ID: 18365471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cutaneous leishmaniasis, cutaneous-ganglionic leishmaniasis, and transfusional kala-azar].
    ANDRE R; BRUMPT L; DREYFUS B; PASSELECQ A; JACOB S
    Bull Mem Soc Med Hop Paris; 1957 Oct 11-18; 73(25-26):854-60. PubMed ID: 13489484
    [No Abstract]   [Full Text] [Related]  

  • 17. Short report: Development of post-kala-azar dermal leishmaniasis (PKDL) in miltefosine-treated visceral leishmaniasis.
    Das VN; Pandey K; Verma N; Lal CS; Bimal S; Topno RK; Singh D; Siddiqui NA; Verma RB; Das P
    Am J Trop Med Hyg; 2009 Mar; 80(3):336-8. PubMed ID: 19270277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased levels of interleukin-10 and IgG3 are hallmarks of Indian post-kala-azar dermal leishmaniasis.
    Ganguly S; Das NK; Panja M; Pal S; Modak D; Rahaman M; Mallik S; Guha SK; Pramanik N; Goswami R; Barbhuiya JN; Saha B; Chatterjee M
    J Infect Dis; 2008 Jun; 197(12):1762-71. PubMed ID: 18444882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leishmaniasis in Israel and the Palestinian Authority.
    Jaffe CL; Baneth G; Abdeen ZA; Schlein Y; Warburg A
    Trends Parasitol; 2004 Jul; 20(7):328-32. PubMed ID: 15193564
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cutaneous leishmaniasis].
    Hengge UR; Marini A
    Hautarzt; 2008 Aug; 59(8):627-32. PubMed ID: 18626612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.